XML 30 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 67,703 $ 69,026 $ 65,392
Adjustments to reconcile net income to net cash provided by operating activities:      
Loss on early extinguishment of debt 0 0 648
Gain on disposition of property (181) 0 0
Depreciation and amortization of deferred leasing costs 50,502 48,430 48,969
Amortization of deferred debt costs 2,353 2,250 1,985
Non-cash compensation costs of stock and option grants 1,723 1,421 1,521
Credit losses (recoveries) on operating lease receivables, net 859 534 (88)
(Increase) decrease in accounts receivable and accrued income 4,224 (243) 2,424
Additions to deferred leasing costs (6,295) (5,607) (2,716)
Decrease in other assets 742 453 4,511
Increase (decrease) in accounts payable, accrued expenses and other liabilities (691) 1,884 524
Increase (decrease) in deferred income 285 (421) (2,019)
Net cash provided by operating activities 121,224 117,727 121,151
Cash flows from investing activities:      
Additions to real estate investments (37,229) (26,196) (15,781)
Additions to development and redevelopment projects (151,684) (177,485) (101,107)
Proceeds from disposition of property 181 0 0
Net cash used in investing activities (188,732) (203,681) (116,888)
Cash flows from financing activities:      
Proceeds from mortgage notes payable 220,000 15,300 199,750
Repayments on mortgage notes payable (105,593) (42,332) (174,096)
Proceeds from revolving credit facility 123,000 160,000 155,000
Repayments on revolving credit facility (212,000) (48,000) (97,000)
Proceeds from construction loans payable 120,997 82,635 0
Payments for debt extinguishment costs 0 0 (593)
Additions to deferred debt costs (3,453) (404) (9,869)
Proceeds from the issuance of:      
Common stock 2,406 2,238 8,173
Partnership units 16,467 1,505 1,322
Distributions to:      
Common stockholders (56,894) (56,722) (55,523)
Noncontrolling interests (24,336) (21,944) (21,548)
Net cash provided by (used in) financing activities 69,400 81,082 (5,578)
Net increase (decrease) in cash and cash equivalents 1,892 (4,872) (1,315)
Cash and cash equivalents, beginning of year 8,407 13,279 14,594
Cash and cash equivalents, end of year 10,299 8,407 13,279
Supplemental disclosure of cash flow information:      
Cash paid for interest 51,647 46,083 40,725
Accrued capital expenditures included in accounts payable, accrued expenses, and other liabilities 20,997 31,166 19,006
Series D Cumulative Redeemable Preferred Stock      
Distributions to:      
Distributions to preferred stockholders (4,594) (4,594) (4,594)
Series E Cumulative Redeemable Preferred Stock      
Distributions to:      
Distributions to preferred stockholders $ (6,600) $ (6,600) $ (6,600)